Reaction Details  Report a problem with these data
Target
Kallikrein-5
Ligand
BDBM50522495
Substrate
n/a
Meas. Tech.
ChEMBL_1886792 (CHEMBL4388469)
IC50
40±n/a nM
Citation
 Walker, AL; Bingham, RP; Edgar, EV; Ferrie, A; Holmes, DS; Liddle, J; Polyakova, O; Rella, M; Smith, KJ; Thorpe, JH; Wang, Y; White, GV; Young, RJ; Hovnanian, A Structure guided drug design to develop kallikrein 5 inhibitors to treat Netherton syndrome. Bioorg Med Chem Lett 29:1454-1458 (2019) [PubMed]  Article
Target
Name:
Kallikrein-5
Synonyms:
KLK5 | KLK5_HUMAN | Kallikrein 5 | SCTE | kallikrein-related peptidase 5 preproprotein
Type:
PROTEIN
Mol. Mass.:
32031.72
Organism:
Homo sapiens (Human)
Description:
EBI_12584
Residue:
293
Sequence:
MATARPPWMWVLCALITALLLGVTEHVLANNDVSCDHPSNTVPSGSNQDLGAGAGEDARSDDSSSRIINGSDCDMHTQPWQAALLLRPNQLYCGAVLVHPQWLLTAAHCRKKVFRVRLGHYSLSPVYESGQQMFQGVKSIPHPGYSHPGHSNDLMLIKLNRRIRPTKDVRPINVSSHCPSAGTKCLVSGWGTTKSPQVHFPKVLQCLNISVLSQKRCEDAYPRQIDDTMFCAGDKAGRDSCQGDSGGPVVCNGSLQGLVSWGDYPCARPNRPGVYTNLCKFTKWIQETIQANS
  
Inhibitor
Name:
BDBM50522495
Synonyms:
CHEMBL4435372
Type:
Small organic molecule
Emp. Form.:
C23H26N6O2
Mol. Mass.:
418.4915
SMILES:
NC(=N)c1ccc(NCc2nc(c[nH]2)-c2ccccc2)cc1OCC(=O)NCC1CC1
Structure:
Search PDB for entries with ligand similarity: